NYSE:HIMSHealthcare
Hims & Hers (HIMS) Stock Could Be A Bargain After The Pullback
Hims & Hers Health stock has more than tripled over the past three years, yet its recent pullback and mixed valuation score leave the current price debate finely balanced rather than obvious in either direction.
The share price has gained about 336% over three years, which keeps long term holders well ahead even after the recent slump.
Expansion into markets such as Australia can support long run revenue ambitions, while regulatory and legal actions around privacy and drug practices may...